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1.  From bifurcation to bench and 
bedside
The mathematical theory of bifurcations is 
part of dynamical systems theory, which can 
straightforwardly be applied to neurological 
and psychiatric diseases with episodic 
manifestations. The term ‘bifurcation’ in this 
context refers to abrupt changes of brain 
dynamics when some physiological parameter 
values are smoothly changed and, at a critical 
point—the bifurcation point—the qualitative 
structure of the dynamical behavior changes 
towards new pathological dynamics. When 
physiological control is lost in such a scenario, 
the pathological process is called a dynamical 
disease [1]. Epilepsy is the best studied 
neurological dynamical disease where the 
theoretical concepts of bifurcation theory have 
been translated to animal models (bench) and 
clinical studies (bedside) [2].
The theory of such bifurcations, or ‘tipping points’ 
[3], complements experimental and clinical 
neurosciences with mathematical analysis 
and simulations to interpret data and guide a 
principle understanding of the nervous systems 
in health and disease. One particular interest 
is in dening dynamical network biomarkers 
(DNB) as early-warning signals based on an 
analytical understanding of the behavior at the 
imminent tipping point [4-7]. We will focus on 
this in this paper and rstly extend this concept 
to obtain a framework for a systematic evaluation 
of the subtle symptoms that often occur in the 
prodromal phase before the main episodic 
manifestations of chronic disorders. In a second 
step, we suggest using DNB beyond monitoring 
early-warning signals and explore ways in which 
DNB can lead to biofeedback signals in a control 
paradigm for episodic treatment. 
One central aim in translational 
computational neuroscience is to fuse 
dynamical systems theory with control theory 
[8] and drive innovation in therapeutic brain 
stimulation in neurological and psychiatric 
diseases with theoretical concepts. At this 
stage, let us only name two further dynamical 
diseases other than epilepsy [2], first (i), 
Parkinson’s disease, which we do not further 
explore but see [9] and, second (ii), primary 
headaches, which we set the focus on in this 
paper. In these dynamical diseases, theoretical 
concepts are used (i) to illuminate the role of 
the coupling architecture and abnormal activity 
patterns in the subthalamopallidal network 
of the basal ganglia and with that knowledge 
to explain the mechanisms underlying the 
therapeutic ecacy of deep brain stimulation 
in Parkinson’s disease [10,11], and (ii) to 
understand the dynamics of pain as a process of 
central sensitization in the migraine generator 
network and dene neuromodulation targets 
and stimulation protocols for episodic 
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migraine treatment [12] that possibly can also 
be explored for neuromodulation in cluster 
headache [13], though we will focus mostly on 
migraines. 
A brief note on the history is due. Despite the 
fact that the elds of translational computational 
neuroscience and neuromodulation are still in 
their relative infancy, let alone their fusion, they 
both actually have a long partly overlapping 
history. Neuromodulation for example in form 
of non-drug treatment in headache dates back 
to the mid-first century CE to Scribonius Largus, 
a physician who practiced at the court of the 
Roman Emperor Claudius and who recognized 
the seemingly benecial eects of discharges 
from electrical sh in headache [14]. Not 
astonishingly, these primitive neuromodulation 
concepts gained much new interest in the 
19th century, when Emil du Bois Reymond— 
himself a migraine suerer—devised the rst 
very precise instruments for measuring and 
monitoring electrical biosignals and his pupil 
Julius Bernstein developed the first membrane 
theory of electrical resting and action potentials 
in neurons. At the same time, driven by the 
industrial revolution James Clark Maxwell 
invented closed-loop feedback to control the 
speed of steam engines, which provides the 
rst theoretical framework that later led to the 
eld of cybernetics as the scientic study of 
“control and communication in the animal and 
the machine” [15]. The modern aspects of this 
eld with some further notes on the history 
have been recently described in the textbook 
entitled “Neural control engineering: the 
emerging intersection between control theory 
and neuroscience” [16].
In the following, we first briefly introduce 
dynamical network biomarkers (Sec. 2) and 
then adapt the concept DNB to chronic 
disorders with episodic manifestations (Sec. 
3) and highlight migraine as an example 
(Sec. 4). To this end, we introduce migraine 
theories (Sec. 5) and computational models of 
spreading depression (Sec. 6) on microscopic 
and macroscopic scale where the concept of 
DNB must be applied. We end with an overview 
of neuromodulation and concluding remarks 
(Sec. 7).
2.  Dynamical network biomarkers
Traditional biomarkers are some objectively 
measured and evaluated indicators of a 
particular biological state that occurs in 
association with a pathological process. 
Usually static measurements of some traceable 
substances are called biomarkers. Also genetic 
biomarkers exist, dened as mutations or 
polymorphisms that predict some clinically 
relevant measure for example risk of disease, its 
outcome or response rate to treatment.
In contrast, a DNB is a dynamical feature 
of a biological network under consideration. 
Such features were originally suggested to 
be of particular interest in complex diseases 
with sudden deterioration phases or critical 
transition points during their progressions 
[4,5]. Depending on the progression level of 
such disorders three stages are distinguished: 
a normal state, a critical pre-disease state, and 
a disease state (Figure  1). The normal state is 
a steady state with functional homeostatic 
control, representing a (relatively) healthy 
stage yet maybe in an incubation period. The 
critical pre-disease state is still clinically silent 
and is considered as the state just before the 
first clinical onset. Mathematically, the critical 
pre-disease state is defined as the limit of the 
normal state immediately before a well-defined 
tipping point is reached. Finally, the disease 
state is with control failure but otherwise, in 
particular from a mathematical perspective, 
also simply a stable state. 
A DNB is essentially a group of traceable 
substances or, in general, signals that while 
highly fluctuating are strongly correlated only 
during the pre-disease stage. Therefore a DNB 
is dierent from the conventional biomarkers 
in two ways. First, it is not required for DNBs 
to keep consistent values for the respective 
disease and normal samples. Only the presence 
of highly fluctuating and strongly correlated 
signals is important. Second, the aim of DNB 
is to detect the pre-disease state, i.e., early-
warning signals associated with the imminent 
tipping point, but not to distinguish the 
respective disease and normal states.
If the pre-disease state is detected by a DNB, 
early treatment can be started, see Figure 1. It 
was first analytically shown that a DNB serves as 
an early-warning signal by defining particular 
but rather abstract critical states as coherent 
subnetworks that were then recognized as 
the physiological correlate of the pre-disease 
state. DNBs were successfully identified in 
Figure 1.  Schematic illustration of the dynamical features of disease progression from a normal state to a disease state through a pre-disease state (modified from [4]). (a) 
The normal state is a steady state or a minimum of a potential function, representing a relatively healthy stage. (b) The pre-disease state is situated immediately 
before the ‘tipping point’. At this stage, the system is sensitive to external stimuli and still reversible to the normal state when appropriately interfered with. A 
small change in the parameters of the system may suffice to drive the system into collapse, which often implies a large phase transition to the disease state. When 
the system approaches the pre-disease state, the deviations of the set of nodes (3, 4, 7) increase drastically, and the correlations (positively or negatively) among 
them also increase drastically whereas their correlations with other nodes (1, 2, 5, 6) decrease drastically. We call (3, 4, 7) the DNB. (c) The disease state is the other 
stable state or a minimum of the potential function, where the disease has seriously deteriorated and thus the system is usually irreversible to the normal state.
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medicine for lung injury disease, liver cancer, 
and lymphoma cancer [4,5].
 3.  Chronic disorders with episodic 
manifestations — dynamical 
systems theory view
The idea of a transition in form of a sudden 
deterioration from the health to the disease 
state via a specifi c pre-disease state can be 
transferred to the cycle of recurrent episodic 
symptoms in chronic disorders. The pre-disease 
state corresponds there to the prodrome, 
a stage that is relatively clinically silent but 
subtle symptoms announcing the ictal phase. 
It is worthwhile noting that the theoretical 
concepts are completely independent of the 
application and can be transferred to various 
complex systems. Early-warning signals 
near tipping points exist in systems ranging 
from medicine to fi nancial market (and their 
crashes), to power grid systems to which a large 
amount of renewable energy is introduced, to 
ecosystem, and to the global climate system [3]. 
Many common neurological and psychiatric 
disorders  t into the category of chronic 
disorders with episodic manifestations 
including not only migraine and epilepsy but 
also stroke, multiple sclerosis, sleep-wake 
disorders, addictive disorders, schizophrenia 
and depression. But, it remains to be 
investigated which are likely candidates for 
dynamical diseases, which, we de ne here, 
accompany abrupt changes in natural rhythms 
in some organ systems due to bifurcations.
The existence of a prodrome with subtle 
symptoms before the ictal phase is a promising 
indicator of such a mechanism based on a 
bifurcation that shows early-warning signals. 
A prodrome stage is actually what would be 
expected from DNB being a subnetwork that is 
both highly fl uctuating and strongly correlated 
but still in the physiological range. So let us 
consider again the two ways described before 
in which DNBs are diff erent from conventional 
biomarkers. If the concept is transferred to 
chronic disorders with episodic manifestations, 
DNBs are by defi nition only present during 
the prodrome. Therefore, the DNB should 
be considered as the neural correlate of the 
prodrome. In other words, the existence of DNB 
is not a prediction in these cases but rather 
one possible a posteriori explanation for the 
prodrome.
The cycle of recurrent episodic manifestations 
is illustrated in a simpli ed way in Figure  2. 
The states are associated to a potential 
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Figure 2.  Possibly dynamical scenario of recurrent episodes as a cycle (a)-(d) in chronic disorders (disease state) vs normal state (e) described in pictorial ‘landscapes’. (a) 
interictal: stable state where the disease under control; (b) prodrome: when the state escapes over the potential barrier to a relative fl at plateau, the transient 
meta stable state is characterised by a strongly fl uctuating and correlated subnetwork (cf. Figure 1); (c) ictal: at a certain point, the episodes manifest in form of 
a transient excursion that is recovered in (d) postdrome (possibly changed landscape); (e) normal state remains stable because the potential barrier toward the 
ictal state is too high. (f ) Additional premonitory symptoms such as migraine aura or aura in epilepsy indicates the existence of diff erent plateaus (cf. Figure 3). (g) 
Chronifi cation of diseased state: landscape changes such that the attack state persists.
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function with a steady state or a minimum of 
this potential function corresponding to the 
attack-free interval and a prodrome phase 
corresponding to a plateau level, which can be 
reached by spontaneous fl uctuations that are 
able to escape the potential barrier from the 
minimum level to the plateau level. At the far 
end of the plateau level, the ‘ictus’ is marked as 
the state that initiates the attack. The plateau 
leads to long transients and DNB dynamics, see 
also Figure  3. Long transients dynamics were 
for example also suggested in a neural mass 
model of epileptogenic tissue [17]. However, 
another possible landscape is that of a bi-stable 
regime, for example, the dynamics of epileptic 
phenomena were determined from statistics of 
such ictal transitions without occurrence of a 
prodrome phase and DNBs [18]. 
For a DNB being possibly an a posteriori 
explanation for the prodrome sets the aim 
expressed by the second di erence between 
DNB and classical biomarkers (see Sec. II) 
into a broader perspective. While in complex 
diseases with sudden deterioration phases 
the aim of DNB is to detect the pre-disease 
state, now in chronic disorders with episodic 
manifestations the question is: What is the 
neural correlate, i.e., what is the DNB, of the 
prodrome?  The aim could still be to more 
reliably detect the prodrome stage. However, 
migraine patients, for example, already very 
often can correctly predict upcoming attacks 
by their premonitory prodromal symptoms 
[19]. Thus, the broadened aim is to use the 
understanding of the slow and still gradual 
physiological changes in the prodrome to 
prevent the imminent abrupt attack, that is, 
to quantify the prodrome by DNB to construct 
a biofeedback signal for therapeutic control 
techniques.
 4.  Primary headaches as 
examples
The theoretical concept of early-warning 
signals is independent of its application [3] 
and the concept of DNB is actually a model-
free concept [4,5]. Still specifi c computational 
models are needed to approach the broadened 
aim of therapeutic strategies. We cannot 
outline the potential use of DNB as early-
warning signals in general terms and therefore 
focus on primary headaches and in particular 
on migraine. Migraine patients can very often 
correctly predict with premonitory symptoms 
their attacks [19] and various neuromodulation 
methods are today available to treat headaches 
[13]. Furthermore, computational models 
of migraine exist and describe the complex 
processes on a wide range of time and space 
scales, see Figure 4. 
Migraine is a primary headache disorder 
characterized by recurrent episodes of head 
pain, often throbbing and unilateral sometimes 
preceded by neurological symptoms called 
aura. The known pathophysiologic mechanism 
suggests that this disorder should be 
considered as a neurovascular headache [20]. 
Migraine is a highly disabling disorder being 
according to the World Health Organization 
the seventh most disabling in the world and 
the fourth most disabling among women. 
Cluster headaches are also a primary headache 
disorder and the brainstem structures and 
subnetworks discussed below are also involved 
in cluster headache so that these concepts 
can likely be applied in some form to cluster 
headache, too.
Note that migraine is a chronic disorder 
with episodic manifestation, also referred to as 
episodic migraine, while the relative new term 
’chronic migraine’ (CM) refers to chronifi cation 
of the recurrent attacks, that is, more than 15 
headache days per month over a 3 month 
period, at least 8 migrainous, and in the 
absence of medication overuse.
In migraine without aura (MO), attacks are 
usually associated with nausea, vomiting, 
sensitivity to light (photophobia) and sound 
(phonophobia), and attacks are worsened by 
movement. Migraine with aura (MA) involve 
in addition—but also rarely exclusively—
neurologic symptoms (called aura) [21]. 
Migraine aura symptoms are most often 
visual field disturbances, but affect also other 
sensory modalities or cognitive functions 
[22]. Aura symptoms are caused by a wave 
of cortical spreading depression. Whether 
this wave also contributes to the headache 
phase in migraine is currently debated [23]. 
Epidemiological studies suggest that MA 
and MO share the same headache phase. 
However, on average the pain seems to be 
less severe and shorter lasting in MA than in 
MO [24]. 
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Figure 3.  Schematic illustration of the ‘landscape’ in a macroscopic model of SD (for details see Sec. 6.2). (a) 
Reaction-diff usion systems describe excitable media that support traveling waves and can engulf a 
cortical hemisphere. (b) Cortical folding modulates the pattern forming features. (c) Additional mean 
fi eld control can stabilize localized SD structures. (d) A critical slowing down of localized SD structures is 
observed in a model with large mean fi eld feedback control and the patterns are modulated (breathing 
spots) in curved geometries.
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The migraine cycle can be divided in four 
distinct stages and the headache-free interictal 
interval. The prodrome is characterized by 
feeling tired and weary, di  culty concentrating, 
yawning, polyuria, sweating, and fatigue are 
some typical features [19]. It lasts up to one 
day and occurs in about 60% of the reported 
cases. During the aura phase, all kind of sensory 
disturbances, visual most frequently, are 
reported. This phase lasts 5-60min and occurs 
in about 30% of the reported cases. Migraine 
headache is often unilateral and throbbing—
though interestingly from a dynamical 
systems theoretical point of view, this seems 
to be not related to blood pulsation but is 
a signature of rhythms in the brain [25,26]. 
Migraine headaches last 4-72 hours and occur 
in about 95% of the cases. Last, the postdrome 
is characterized by tiredness, di  culty 
concentrating, weakness, dizziness, persistence 
of sensitivity to light and noise, lethargy, and 
fatigue, together often described as ‘headache 
hangover’. It lasts a few days and occurs in 
about 70% of the reported cases. Together with 
the attack-free interval these phases compose 
the migraine cycle with associated severe 
disabilities and reduced quality of life even 
between attacks [27].
 5. Migraine theories
While we expect that quantitative methods such 
as computational neuroscience will become 
increasingly important in migraine research 
to keep up with the proliferation of imaging 
data and to con ne current theories, it was the 
advent of non-invasive imaging that changed 
the view on this headache type in the  rst place 
with some intriguing qualitative observations. 
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Figure 4.  Migraine aff ects neural activities across all levels. (a) Rare monogenic subtypes exist and genome-wide association study have revealed susceptibility loci for 
migraine with and without aura. (b) Disturbed functions of ion channel, proteins that regulate them, and pumps can be modeled by ion-conductance-based 
models. (c) Neuronal subpopulations and local circuits in specifi c brain regions, in particular, the layered cortex have also been investigated. (d) Higher-order 
networks of central nuclei and peripheral ganglia form the migraine generator network and its dynamical state may change during the course of an attack (e)-(f ). 
(g) Sensory processing can be perturbed in particular during the aura phase and behavioral changes occur in the prodromal phase such as food craving that can 
lead to false interpretation of triggers. (See main text for further detail.) 
 
Translational Neuroscience
Brought to you by | University of Aberdeen
Authenticated
Download Date | 3/18/16 12:55 PM
287
In the 1980s and into the mid-1990s, it became 
clear by studies of the clinical features of 
migraine and its physiological mechanisms that 
there is no clear correlation between blood flow 
changes and the headache but instead imaging 
studies suggested [28] that upstream events 
in the brainstem named ‘migraine generator’ 
(MG) [29] lead to the cascade resulting in 
migraine pain. Furthermore, imaging migraine 
with aura revealed that the phenomenon of 
cortical spreading depression (SD) is the neural 
correlate of migraine aura [30,31]. To date, the 
MG and SD theories are facing each other but 
are probably not irreconcilable.
In brief, the MG theory states that a 
dysfunction of the brainstem causes the pain 
and via further connections (directly and 
indirectly) the brainstem is also responsible for 
the neurological changes before the headache 
phase including symptoms in the prodromal 
phase and the aura phase, in particular, the 
MG is causing SD via a failure of vasomotor 
control (Figure 4d). The SD theory of migraine 
assumes that this cortical wave causes the 
neurological systems (aura) [32] and it can also 
cause the pain in the headache phase, which 
usually occur after the aura phase, but cf. [33]. 
In this theory, two independent pathways 
of increased pain trac are suggested, a 
peripheral and a central pathway. The headache 
pain can either be triggered by a local release 
of noxious or inflammatory substances during 
the hyperemic phase of SD [23,34]. These 
substances are thought to be transmitted 
outward in the direction perpendicular to 
the cortical layers into the pain sensitive 
meninges. This transmission results in an 
activation of pain receptors (nociceptors) and 
local inflammation, which eventually triggers 
the migraine headache (peripheral pathway, 
Figure 4e). Or the alternative explanation is that 
SD leads to pain by a corticothalamic feedback 
that affects sensory processing by third-order 
neurons arising within the sensory thalamus. 
This is supported by the ecacy of calcitonin 
gene-related peptide receptor antagonists at 
the level of these neurons in migraine therapy 
[35] (central pathway, Figure  4f ). Probably, 
a combination of the peripheral and central 
pathway leads to this complex disorder and 
quantitative models as outlined below can help 
to disentangle the relative contributions and 
dependencies.
6.  Computational models in 
migraine
Computational models of spreading depression 
date back to the mid-1970s. A simple rule-based 
cellular automata model was used to mimic the 
two-dimensional spread on the cortical surface, 
including spiral-shaped SD waves reentering 
around a functional block [36] that can also 
be observed experimentally [37]. Partial 
dierential equations were used to describe 
the detailed physiological cellular events [38]. 
For a detailed review of SD modeling, including 
the mathematical description, see the excellent 
review by Miura et al. [39]. In the following, only 
basic approaches focusing on the principles of 
cellular dynamics and tissue pattern formation 
in SD are introduced. We start with cellular 
dynamics of SD and continue with the events in 
cortical tissue. The mathematical equations are 
given in an Appendix.
6.1  Cellular dynamics in SD
The focus in computational models of the 
cellular dynamics in SD is on transmembrane 
events that can be observed in in vitro 
experiments [40]. The advantage of such 
experiments is that the phenomenon of SD 
can be studied in isolation and the complex 
vasomotor feedback involved in SD can be 
neglected [41], though current modeling 
approaches include metabolic and perfusion 
effects on SD [42]. With this local focus set, 
SD is essentially a massive but temporary 
perturbation of ion homeostasis. The ion 
concentrations are under physiological 
conditions kept within a narrow range and 
their gradient across the cell membrane is 
treated in traditional computational models 
of Hodgkin-Huxley (HH) type as a constant 
battery, the reversal potential or Nernst 
potential [43]. During SD, however, ion 
concentrations can change by over one order 
of magnitude, so that the original HH approach 
to describe the potential changes across the 
excitable membrane must be extended. For 
instance, during SD the extracellular potassium 
concentration raises from 3mM within a 
few seconds to peak values around 55mM, 
plateaus at this level for about 30 seconds 
and recovers to the physiological range 
within one to two minutes [32]. Furthermore, 
neuronal activity is depressed due to the nearly 
complete elimination of the transmembrane 
ion gradients, in other words, the cells release 
almost all of their available energy—the Gibbs 
free energy—the supply for physiological 
neural activity [44]. This depressed activity 
state can spread throughout gray matter in the 
brain, hence this activity is named as SD (see 
below the section on spatial patterns forming 
in cortical tissue).
To model local cellular events in SD, 
Kirchhoff’s current law is used as first introduced 
in the HH framework [43]. The major extension, 
however, is that in addition to the original 
transmembrane potential V and the variables 
activating and inactivating conductances of 
transmembrane channels (voltage-gating 
variables, usually called m, n, and h) further 
functions and dynamic variables for the ion 
homeostasis are introduced. First, an ATP 
driven ion pump is modeled that exchanges 
intracellular sodium ions with extracellular 
potassium at a 3/2 ratio and therefore changes 
not only ion concentrations dynamically but 
also leads to a depolarizing transmembrane 
current Ipump. Second, extracellular and 
intracellular ion concentrations become 
dynamic variables and thus increase the phase 
space of the model. We refer to the Appendix A 
for the corresponding mathematical equations. 
Such an extended framework is able to model 
the long lasting dynamics on time scales of 
minutes, while, for example, a single action 
potential, which is described in the rst 
generation HH-type framework, lasts about a 
millisecond, a time scale separation of about 
five orders of magnitude. This new time scale 
separation is the fundamental characteristic of 
this second generation HH-type framework. 
The first generation of HH-type models for 
single cells is also called conductance-based 
models. In the parallel development of neural 
mass models for cell populations one often 
refers to rate- or activity-based modeling. 
In each case, the model is named after the 
respective dependent dynamical variables 
other than the transmembrane potential. In 
this terminology, the second generation HH-
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type models necessary to model SD are ion-
conductance-based models. Note that ion-
conductance-based models are necessarily 
‘tissue-embedded’ single cell models because 
the amount of cell membrane surface area per 
unit tissue volume, in short, the surface area-to-
volume ratio plays a significant role. While this 
factor does not affect HH type conductance-
based models, in ion-conductance-based 
models it gives rise to the long time scale of SD 
excitation cycles as compared to much shorter 
actions potentials and may likewise cause slow 
modulations of activity in extended rate- or 
activity-based neural mass models.
With an ion-conductance-based model 
of a total of 9 dynamical variables the main 
features of SD that happen across the cell 
membrane can be modeled (see Figure  4b). 
Using electroneutrality and further symmetry 
constraints, ion-conductance-based models 
can be further reduced and become amenable 
for bifurcation and geometrical phase 
space analysis. On the other end towards 
physiologically more realistic ion-conductance-
based models of SD, several dozens of 
dynamical variables in various electrically 
coupled neural compartments (~200, which 
eectively multiplies the number of dependent 
dynamical variables) can be modeled in tissue-
embedded single cell models [39,45-47]. 
Although in reduced ion-conductance-
based models the time course of the dynamic 
variables can be to some extent distorted as 
compared to more realistic models [39,45-47], 
main features of SD are revealed (Figure  4b). 
Two phases and three points stand out because 
of their significant mechanistic meaning in SD 
as an excitation phenomenon: the seizure-like 
afterdischarges, the subsequent excitation 
block, the begin of a INa-driven transient 
repolarization, the m-gate deactivation that 
nally initiates a phase where the pump current 
Ipump can become dominant, see Figure 4b. 
Of all these events highlighted in Figure 4b 
most notably is the recovery phase of SD at 
around 24.5 s. According to the computational 
models, recovery is due to a deactivation of the 
sodium activator m driven by a dominat INa that 
actually repolarizes V shortly after the seizure-
like firing stops due to a depolarization block. 
After the deactivation of the sodium activator 
m, the pump current Ipump drives the membrane 
potential V (black) for several seconds outside 
the window of the two reversal potential of 
sodium and potassium, ENa (red) and EK (blue), 
respectively. The ignition of SD is due to a torus 
bifurcation (not shown, unpublished results) of 
the tonic seizure-like firing caused by the initial 
stimulation phase. This suggests that after 
the offset of the stimulation at 0.5 s the state 
of the dynamical system is already behind a 
canard-like trajectory that serves as a threshold 
causing firstly a brief phase of sustained (2-3 
s) afterdischarges and then a long lasting 
recovery phase during which the system is 
refractory.
Next, we consider large-scale tissue events 
caused by SD. But before that it is worthwhile 
noting that cellular models often do not 
include lateral space, except for the original 
work by Miura and Tuckwell [38] and some 
recent approaches from the group of Miura 
[48] and an isolated work by Shapiro [46] 
considering osmotic forces and gap junctions. 
The compartments mentioned before extend 
in the vertical direction to model the apical 
dendritic tree of pyramidal cells in the cortex 
[45,47]. But the very detailed models by 
Kager, Wadman, and Somjen are not spatially 
extended to describe the lateral extension, 
that is, they describe SD not as an excitable 
phenomenon in a spatially extended system, 
called excitable media. 
The lateral extension of cellular SD models 
is far from straight forward. Naively adding 
diusion to the extracellular dynamical ion 
concentrations yields some insights but it 
does not reflect the necessary detail of neural 
microcircuits that needs to be considered to 
take the spatial continuum limit (Figure  4c). 
Neural eld models, for example, describe 
this limit for rate- or activity-based neural 
mass models [49]. The problem is that the 
neural tissue is heterogeneous and the cell’s 
embedding needs to be considered in quite 
some detail for a lateral extension of cellular 
SD models. A bottom-up approach toward 
an ion-conductance-based medium model 
that lacks the support of an eective medium 
theory cannot expand from membrane to 
tissue level in a canonical way and therefore 
loses its advantage over the simpler top-down 
approaches. Likewise, a coarse-graining in 
time from individual spiking to rate or activity-
based dynamics in simulated cell populations is 
needed for the relevant time scales in migraine. 
A rst promising approach was made with 
an ion-conductance-based model in seizure 
spread [50].
6.2  Tissue events caused by SD
The Gibbs free energy-depleted and activity 
depressed state of SD described in the former 
section can spread through gray matter tissue 
by electrodiusion due to newly formed ion 
gradient along the membranes in the neuronal 
and glial syncytium and the interstitial volume. 
In accordance with noninvasively imaged 
SD progression using high-field functional 
magnetic resonance imaging (fMRI) [31] and 
reported visual eld defects [51], a macroscopic 
computational model of SD (see Appendix 
B) was proposed in which to each episodic 
migraine attack a particular spatio-temporal 
SD pattern is formed [12,52]. With this model 
a mechanism was suggested to explain the 
shape of SD in migraine as a discontinuous 
wave segment that spreads out in only one 
direction. In a nutshell, the mechanism is based 
on dissipative structures as self-organized 
localized solitary patterns [53,54] that 
become transient objects with critical slowing 
down—from a mathematical point of view a 
mechanism similar to the one of DNB—that is 
modulated by cortical folding, see Figure 3.
These are the tissue events of SD that are of 
clinical importance for migraine because we 
predict that they will determine not only the 
migraine aura but also the headache phase 
for two reasons. First, the spatio-temporal 
patterns of SD determine the transmission 
of noxious or inflammatory mediators in 
the direction perpendicular to the cortical 
surface into the pain sensitive meninges and 
then via peripheral pathway (Figure 4) the 
headache phase. This transmission must be 
signicantly convergent to reach noxious 
threshold concentrations, whereby likewise 
the considerable heterogeneity of increased 
nociceptor density around pial arteries and 
dural venous sinuses can interfere with the 
distinctive self-organized patterns in the folded 
cortex. Second, the particular spatio-temporal 
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pattern of SD probably also determines via the 
central pathway the specic corticothalamic 
feedback that aects sensory processing in 
terms of sensitization by third-order neurons 
(Figure  4f ). We suggested that the two major 
migraine subtypes, MO and MA, depend on the 
spatial SD patterns and the bifurcation that is 
responsible for their transient nature one being 
without critical slowing down and one showing 
critical slowing down, respectively [12,52].
The major advantage of generic, i.e., low 
dimensional, reaction-diffusion models of SD 
lies in the fact that they provide insight in the 
phase space structure of the whole class of 
models they represent. In fact, localized solitary 
patterns are not the only SD waves in the 
human cortex of clinical relevance. Re-entrant 
SD waves are believed to have the potential to 
worsen stroke outcome in incremental steps 
with each wave circling near the infarct core, 
while the same SD wave in the penumbra zone 
far from the infarct tissue could also have a 
benecial component by stimulating blood 
flow [55]. The infarct core is a static anatomical 
block, whereas spiral waves and localized 
SD waves in migraine have a variable core 
(functional block) and variable left-off tissue, 
respectively [37,56]. These and other clinically 
important spatial pattern forming mechanisms 
can be understood in terms of phase space 
structures. These structures describe the 
migraine aura–ischemic stroke continuum as 
transitions of two-dimensional wave pattern 
in SD from retracting localized (migraine) to 
stationary waves (persistent migraine aura 
without infarct) to re-entrant waves (stroke) 
[57]. Therefore, the precise spatio-temporal 
SD pattern formation is of immense clinical 
interest [58]. 
To simulate the clinically observed patterns 
in migraine [31,51], a generic reaction-diffusion 
mechanism can be described in abstract 
terms of activator-inhibitor kinetics. In fact, 
simple activator-only kinetics date back to 
a mechanism of SD described in 1963 by 
Grafstein based on an otherwise unpublished 
suggestion by Hodgkin and Huxley, to date 
called the Grafstein-Hodgkin-Huxley (GHH) 
model [59]. The GHH model assumed that the 
extracellular potassium ion concentration is 
an activator in SD. We extended this scheme 
by introducing two inhibitory mechanisms, 
an immobilized inhibitor and a mean eld 
inhibition (for details of the full model see [52]).
The abstract activator and inhibitor variables 
are lump variables. Unlike in the original GHH 
model, it is not necessary or even possible to 
identify particular physiological quantities, like 
[K+]e, with them. Instead, the activator should be 
viewed as a positive feedback element with a 
bistable energy state. The activator and inhibitor 
or rather the respective networks of dynamical 
variables that constitute these elements can be 
described in great physiological detail on the 
cellular level (see the former section) yet they 
are also new emerging conceptual quantities 
that allows us to describe the phenomenon of 
SD directly on the macroscopic level. The high 
energy state (a stable fixed point) corresponds 
to the maintenance of homeostasis far from 
thermodynamic equilibrium and the low 
energy state (another stable fixed point) to 
the state where the cellular Nernst reversal 
potentials are eliminated, that is, a state at or 
near the thermodynamic Donnan equilibrium 
[44]. In the presence of inhibitors as recovery 
variables, which were not included in the 
GHH model, the low energy stable fixed point 
becomes a transient state that can spread 
through gray matter tissue by electrodiusion 
as a depleted and activity depressed state.
7.  Concluding remarks on trans-
lating theoretical concepts 
into neuromodulation applica-
tions
The design of new neuromodulation strategies 
in migraine requires to understand how electric 
and magnetic stimulation changes neural 
activity. Even more important are quantitative 
models of the network dynamics during this 
neurological condition to optimize stimulation 
protocols. In Sec. 6.1, we described cellular 
dynamics that are key to understand how 
electric and magnetic stimulation influences 
brain activity. The cellular dynamics are also 
the microscopic foundation of self-organized 
macroscopic tissue events, which are of direct 
clinical relevance. In Sec. 6.2, we show that on 
the macroscopic level SD manifests as a localized 
wave in the human cortex during migraine 
with aura. From the model we can predict that 
the macroscopic spatio-temporal SD patterns 
(shape, size, and duration) determine to some 
extent the clinical manifestation of a migraine 
attack [12].
As we argued in Sec. 5, the spatio-temporal 
SD events can determine the amount of 
noxious input into the pain sensitive structures 
(Figure 4e) as well as modulate corticothalamic 
feedback loops (Figure  4f ). However, the 
question about the most upstream event 
in the course of a migraine attack that 
would directly lead to the optimal target of 
preventative intervention is probably too 
naive. The ignition of SD is currently unknown 
but a failure of vasomotor control from the 
brainstem, which is part of the MG theory, 
is a likely scenario (Figure  4d). It further is 
plausible that these SD waves will in turn also 
affect the brainstem activity because SD itself 
causes a complex vasomotor reaction [41]. 
This allows only one conclusion: Migraine is an 
inherently dynamical disease with a complex 
network of interdependent events rather than 
a disease with a linear course from upstream 
to downstream events, a course that is also 
called into question by a rather variable cycle of 
recurrent episodic symptoms in migraine with 
phases such as the aura that occurs only in a 
fraction of the individual attacks [60]. 
The central question therefore is about 
dierent brain structures and in which phase 
of the migraine cycle they are promising 
neuromodulation targets (Figure  5) in the 
framework of complex dynamical systems 
and control theory [8]. We still lack a unified 
quantitative model combining the events in SD 
theory and MG theory of migraine (Sec. 5) to 
interpret their relation, simulate the impact of 
potential neuromodulation intervention, and 
make concrete predictions about optimized 
stimulations protocols that can be tested. 
In this situation, however, the theoretical 
framework of DNBs provides a sound basis to 
address these challenges because DNBs are 
based on a model-free concept and, if DNBs 
can be identied in migraine, they will help to 
develop a unified theory. Namely, DNBs will not 
only show whether a symptom is approaching 
or not, but also help to construct such a unied 
model explaining how the symptom appears, 
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and providing a feedback-control-scheme to 
suppress the symptom.
We end this review by introducing briefl y two 
neuromodulation techniques that are currently 
investigated in migraine in two di erent phases 
of the migraine cycle targeting two di erent 
brain structures. Then, we speculatively 
suggest a promising third neuromodulation 
technique that may be of particular use during 
the prodromal phase that could refl ect a DNB 
(cf. Sec. 3). Furthermore, we also suggest 
taking the attack-free interval into account for 
prophylactic intervention.
Note that, as of to date, there is no approved 
indication for neuromodulation with electric 
or magnetic stimulation for episodic but only 
for chronic migraine (>15 headache days per 
month). In fact, due to the severeness of pain, 
most neuromodulation studies in headache 
research are or have been conducted among 
patients with refractory cluster headache. 
However, the  eld is rapidly increasing [13] and 
given that newer devices require noninvasive or 
minimally invasive implant surgery involving a 
new generation of intelligent control methods 
also less disabled patients with high frequency 
episodic migraine with unsatisfactory 
treatment response could bene t from e  cient 
neuromodulation.
 7.1   Transcutaneous electrical nerve 
stimulation
Transcutaneous and transcranial (see the 
next subsection) stimulations are the two 
noninvasive modes currently at hand. The 
transcutaneous electrical nerve stimulation 
(TENS) modulates neural activity by targeting 
noninvasively peripheral nerves. In migraine, a 
supraorbital transcutaneous stimulation (STS) 
was tested with a portable device that looks like 
a silver headband and targets the ophthalmic 
division of the trigeminal nerve that terminates 
in the central trigeminal nucleus caudalis (TNC) 
and the C1-C2 regions of the cervical spinal 
cord, together known as the trigeminocervical 
complex (TCC), see top right in Figure 5. 
In a recent study, the stimulation was tested 
with biphasic rectangular AC impulses at 60Hz. 
The therapeutic gain (26%) is within the range 
of those reported for other preventive drug 
and nondrug migraine treatments [61]. The 
mode of action or even quantitative methods 
to test paradigms are currently missing, though 
it seems plausible that if central sensitization 
of second-order neurons is causing migraine 
pain, this method is suppressing the inbound 
sensory tra  c which could add to sensitization, 
and it should therefore be used in the acute 
headache phase rather than prophylactically.
 7.2   Transcranial magnetic and 
electrical stimulation
The transcranial stimulation targets not 
peripheral neurons but the cortex. Two 
noninvasive neuromodulation techniques are 
available in migraine, transcranial magnetic 
stimulation (TMS) and transcranial electrical 
stimulation (TES). A recent carefully sham-
controlled larger trial with a portable TMS 
device was undertaken as a promising 
noninvasive neurostimulator for disrupting SD 
early in the aura phase [62], see bottom right 
in Figure  5. The results (eff ective in aborting 
migraine attacks) of this sham-controlled study 
were promising, i.e., it seems to disrupt SD, but 
that would limit its use to the acute aura phase. 
However, considering the concept of silent aura 
Figure 5.  Various neuromodulation techniques are currently investigated in chronic migraine, but note that, as 
of to date, there is no approved indication for neuromodulation with electric or magnetic stimulation 
for episodic migraine. We suggest to investigate these techniques also in episodic migraine and to 
use quantitative models and modern control theory to determine an optimal stimulation protocol, 
target structure and phase within the migraine cycle. Photograph top left (SPG stimulation): courtesy 
Autonomic Technologies, Inc. © 2013. Inset fi gure top right: courtesy of STX-Med © 2013. Photograph 
bottom right (TMS device): courtesy of Neuralieve, Inc. © 2013 (trading as eNeura Therapeutics). 
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[63] and the mathematical model for SD [52], 
TMS could potentially be eective when used 
in the very early headache phase targeting 
the shorter lasting phase of SD. In either case, 
there is a clear need for further studies and the 
optimization of the stimulation protocol for 
targeting localized spatio-temporal reaction-
diusion patterns [52].
The simplest technology with the least safety 
issue is probably TES. Two versions of TES exist, 
the transcranial direct current stimulation 
(tDCS), in which cathodal tDCS inhibits while 
anodal tDCS increases neuronal firing. The 
alternating current stimulation (tACS) has 
not yet been clinically tested in migraine. 
Preliminary evidence was found for patients 
with chronic migraine having a positive, but 
delayed, response to tDCS applied to motor 
(anodal) and oribitofrontal (cathode) cortices 
[64]. In addition, computational simulations of 
current flow through brain regions were used to 
interpret the effects in this study. With the help 
of such simulations, a principal understanding 
of pain modulation can be gained, whether this 
modulation is due to the effect of TES on SD or 
on the dynamics of the pain matrix and deeper 
structures including thalamus and brainstem. 
Effective prophylactic therapy in migraine was 
also studied with cathodal tDCS over the visual 
cortex with the anode overlying the motor and 
sensory cortices [65]. 
7.3   Sphenopalatine ganglion stimula-
tion
Beside the two mechanism explained by the 
SD theory (Figure 4e, f ), also other mechanisms 
could activate pial and dural nociceptors and 
trigger the pain of the headache phase of 
migraine. It was suggested by Burstein and 
Jakubowski [66] that a common pathway for 
various migraine triggers could be provided by 
the pre- and postganglionic parasympathetic 
neurons in the superior salivatory nucleus (SSN) 
and sphenopalatine ganglion (SPG). A number 
of projections converging in the SSN seem to be 
coming from brain areas that can explain typical 
migraine triggers, for example stress, dietary, and 
external stimuli such as smell. Targeting the SSN 
through antidrome or feedback mechanisms of 
the SPG could therefore be a potential target in 
migraine (prevention).
Interestingly, it was also argued that for 
many if not all of the typical triggers the 
role of cause and eect is actually reversed 
and premonitory symptoms are mistaken as 
triggers [67,68]. For example, eating chocolate, 
as a typical food craving symptom before the 
headache phase of migraine, is a brain-driven 
response within the premonitory phase and 
not a trigger, i.e., the cascade of the attack 
has already started and the only symptom 
at that stage is the craving with all the other 
symptoms still to come. Likewise, sensitivity 
to light (photophobia) during the premonitory 
phase could mistakenly be identied as a 
trigger by light. In the context of DNB this is 
certainly plausible as this concept predicts a 
common subnetwork such as SSN and SPG to 
be involved in the premonitory symptoms.
Given the theory that the pre- and 
postganglionic parasympathetic neurons 
in the superior salivatory nucleus (SSN) and 
sphenopalatine ganglion (SPG) could be a 
common pathway for migraine triggers [66], 
minimally invasive sphenopalatine ganglion 
stimulation might be suited in particular in 
the prodromal phase in episodic migraine. 
A very innovative implantable battery-free 
SPG stimulator has been developed to apply 
on-demand stimulation for the treatment of 
migraine and other primary headache. In a 
pilot study (n=11), the potential of electrical 
stimulation of the SPG has already been 
shown in attack abortion, 2 patients were 
pain-free within 3 minutes of stimulation, 
3 had pain reduction, 5 had no pain relief, 
1 was not stimulated [69]. However, in this 
pilot study, the headache was allowed to 
intensify up to 6 hours before stimulation 
was initiated, where SPG stimulation might 
theoretically be less efficient to influence 
a migraine attack than it could have in the 
prodromal phase. More to the point, a recent 
paper described not only a marked abortive 
but also a preventative effect in cluster 
headache patients [70] which could best be 
explained by feed-back mechanisms from 
the SPG to the SSN and thus underlining 
the above mentioned theory and pointing 
towards the SPG as a suitable target for attack 
prevention. However, all this is based on a 
theoretical concept and it should be noted 
that in migraine research no valid studies 
have been published yet to prove that SPG 
stimulation could have a positive effect in 
this syndrome as well. 
To summarize, already to date various 
neuromodulation methods for treatment 
of primary headache have been studied, 
beside the above mentioned also other 
invasive techniques such as deep brain 
stimulation and minimally invasive occipital 
nerve stimulation [71]. To fully realize the 
potential of computational models that can 
be translated into a new neuromodulation 
paradigm a modern control theory is needed. 
The challenge in the future will be to integrate 
the known mechanisms into a tractable 
theoretical migraine model, but also to obtain 
human data from clinical studies and identify 
DNB. Therefore, new clinical study designs 
are needed to investigate the macroscopic 
dynamics in migraine. For example, fMRI 
brainstem specific ROI-based imaging 
paradigms and fluorodeoxyglucose positron 
emission tomography (FDG-PET) combined 
with magnetic resonance imaging (MRI) could 
identify important neuronal centers in the 
brainstem and describe their connectivity 
pattern [72]. Such imaging methods together 
with quantitative methods and theoretical 
concepts are important to characterize 
dynamics in the migraine generator network 
and identify DNB over several migraine cycles 
in controls and patients suering from episodic 
migraine. 
8  Appendix: Model equations
8.1  Cellular models
To model local cellular events during SD, we 
start with Kirchhoff’s current law that was 
introduced as an equivalent membrane circuit 
by Hodgkin and Huxley [43] 
   (1)
The variable V is the potential dierence or 
voltage across the membrane relative to the 
grounded extracellular side. The cell membrane 
has a capacity Cm. The currents Iion are the 
transmembrane currents with ion ∈{Na+,K+,Cl−}. 
Iapp is an externally applied current.
dV
dt
= − 1
Cm
(INa+ + IK+ + ICl + Ipump − Iapp).
Ipump(Na i, Ke) = ρ
(
1 + exp
(
25− Na i
3
))−1(
1 + exp (5.5−Ke)
)−1
.
-
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In the original HH framework, an unspecified 
leak current was modeled but not a chloride 
current. The major extension, however, is the 
pump current Ipump, which can be modeled for 
example as [73]:
  (2)
The pump current Ipump with pump 
rate ρ describes the ATP driven exchange of 
intracellular sodium ions with extracellular 
potassium at a 3/2 ratio.
The ion concentrations [ion] change due 
to fluxes proportional to the ion currents. The 
additional rate equations for intracellular ion 
concentrations are 
  (3)
with α being 3, 2, and 0 for Na+,K+, and Cl−, 
respectively. The parameter γ converts currents 
to ion fluxes and depends on the membrane 
surface area Am and Faraday’s constant F, γ= 
Am/F. The parameter ω is the volume of the 
intracellular space (ICS). 
In addition, also dynamical gating variables 
n, h and m have to be introduced, as in the 
original HH model. The potassium activator, 
sodium activator and sodium inactivator are 
defined by the voltage-dependent gating 
dynamical variables n, m and h, respectively. 
These are given by 
  (4)
for p∈{n,m,h}. 
8.2  Reaction-diffusion models
To simulate the clinically observed patterns in 
migraine [31,51], a generic reaction-diffusion 
mechanism can be described in abstract 
terms of activator-inhibitor kinetics of just two 
variables u and v, respectively. We extended the 
GHH model (see the main text) in the following 
way (also for details of the full model see Ref. 
[52]): 
  (5)
 
(6)
    
with H being the Heaviside step function and 
the space coordinates are given by x and y. Both 
activator u and inhibitor v are lump variables 
(see the main text). We set the parameter 
as follows: time scale separation ε=0.04, the 
threshold β=1.32, and the mean field coupling 
K=0.003.
There are two stable solutions of this 
model, namely the homogeneous steady 
state and the traveling wave. Moreover, 
there exists a saddle solution forming a 
localized solitary pattern whose stable 
manifold is the basin boundary of the stable 
solutions. By varying a control parameter, 
the stable traveling wave solution and 
the saddle solution collide causing the 
saddle-node bifurcation. The saddle-node 
bifurcation and the critical slowing down 
with this model suggest the applicability of 
DNB to detect SD.
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